Immunotherapy has revolutionized cancer treatment, but it is vital to develop non-invasive methods to evaluate and predict the effectiveness of therapy for individual patients. The advanced imaging techniques that we are developing are very promising for this purpose, but there is much more work to be done. In the next few years, by combining our expertise in molecular biology, chemical biology and immunology, we hope to advance this field.
Furthermore, we aim to better understand the underlying mechanisms of how the tumor microenvironment is shaped and is changed in response to cancer immunotherapies. The lab is focused to develop new and improved diagnostic, prognostic, and therapeutic tools to detect, diagnose, treat, and prevent cancer.